Author name: connect arjuna

FOSTAC Training at CBE Division. Cbe, Edayar & Livlong representatives participating. The Food Safety Training and Certification (FoSTaC) program, initiated by the Food Safety and Standards Authority of India (FSSAI) in July 2017, was implemented by Arjuna Natural in their Coimbatore division. This training and certification ecosystem for food businesses is designed to enhance awareness and understanding of food safety regulations and policies, promoting the highest standards of food safety and hygiene.

Reflecting on the recently concluded International Production & Processing Expo (IPPE), where industry leaders, including Arjuna Natural, came together to drive business development, adopt best practices, streamline operations, and maintain a competitive edge. The event provided a unique platform for cultivating relationships, exploring new suppliers and vendors, and connecting with colleagues, all in one comprehensive gathering. This year, Arjuna Natural actively contributed to the diverse showcase of advancements in solutions, technologies, research, processes, services, and products within the global animal food and nutrition industries at IPPE in Atlanta, GA, USA. It was an invaluable opportunity to stay at the forefront of innovation and engage with industry experts.

Why is clinical research important when selecting ingredients for osteoarthritis formulations? Clinical research helps manufacturers evaluate ingredient performance, safety, and formulation potential for joint health products. Arjuna Natural developed Biocurpain® with scientific research to support evidence-based nutraceutical product development. Background: Osteoarthritis (OA) is a progressive arthritis that decreases quality of life. This disease can not be cured and is limited and can only reduce pain experienced by patients. The drug that is often used is non-steroidal anti-inflammatory drugs (NSAIDs), these medicines can not be separated from side effects if used in the long term. An effective and safe drug is needed to improve functional status in osteoarthritis paitents. Objective: Rizaldy Taslim Pinzon1 *, Eric2 To compared the effectiveness of biocurpain which has a marketing authorization number TR172599281 with NSAIDs to improves functional Status in the treatment of OA patients. Methods: A Randomized Control Trial (RCT) involving OA patients. The treatment used were Biocurpain (Curcuma longa 350 mg and Boswellia serrata 150 mg) and NSAIDs (Ibuprofen 400 mg). Subjects were randomized into 2 groups (Group 1 received Biocurpain and group 2 recieved NSAIDs). Functional status measurement using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Results: There were 67 subjects that participated in this study, 5 subjects were lost to follow-up and 3 subjects could not continue the study due to sideeffects. 59 subjects completed the trial (group 1: 29 subjects and group 2: 30 subjects). There were no significant differences between groups in improving functional status (p: 0.771), the use of rescue medication (p: 0.370), the incidence of adverse events at visit II (p: 0.215) and visit III (p: 0.537) on OA subjects. Group 2 showed more subjects experiencing side effects.Conclusion: Biocurpain as effective as NSAIDs to improve functional status in OA patients. Indonesian Journal of Pharmacy and Pharmaceutical Sciences Vol. 7 No. July 1, 2020 57